Precigen, Inc. Common Stock (PGEN)
PHARMACEUTICAL PREPARATIONS
Precigen, Inc. Common Stock (PGEN) is listed on Nasdaq, where it has traded since August 8, 2013.
- Listed On
- Nasdaq
- Listed Since
- August 8, 2013
- Employees
- 47
- Market Cap
- $2.8B
About Precigen, Inc. Common Stock
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 201 institutions reported holding PGEN, with 140.1 million shares worth $797.5 million in aggregate. The largest reported holder was Patient Capital Management, with 19.0 million shares worth $108.5 million. Of the 5 largest holders listed below, all 5 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Patient Capital Management | 19,036,976 | $109M | Added 6.84% |
| BlackRock | 17,146,921 | $98M | Added 12.64% |
| State Street | 12,002,465 | $68M | Added 10.21% |
| Vanguard | 11,767,187 | $67M | Added 9.22% |
| Diametric Capital | 9,269,926 | $53M | Added 36.29% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is PGEN?
Precigen, Inc. Common Stock (PGEN) is listed on Nasdaq, where it has traded since August 8, 2013.
Who are the largest institutional holders of PGEN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of PGEN were Patient Capital Management, BlackRock and State Street.
How many institutions own PGEN?
201 institutions reported a position in PGEN for the quarter ended June 30, 2026, worth $797.5 million in total.
Did institutions buy or sell PGEN last quarter?
Of the 5 largest reported holders, all 5 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for PGEN.
Every reported institutional holder, plus insider and congressional trades in PGEN, on SentiSense.